Arteris Q4 revenue rises 30%, beats estimates

Reuters
Feb 13
Arteris Q4 revenue rises 30%, beats estimates

Overview

  • Semiconductor technology provider's Q4 revenue rose 30%, beating analysts' expectations

  • Adjusted net loss came in less than analysts' expectations

  • Company completed acquisition of Cycuity for semiconductor security verification

Outlook

  • Arteris projects Q1 2026 revenue between $20.5 mln and $21.5 mln

  • Company expects FY 2026 revenue between $89 mln and $93 mln

  • Arteris sees FY 2026 ACV plus royalties between $100 mln and $104 mln

Result Drivers

  • RECORD ACV AND ROYALTIES - Arteris achieved a record Annual Contract Value plus royalties of $83.6 mln, representing 28% growth year-over-year

  • ROYALTY GROWTH - Company recorded 50% year-over-year growth in royalties, driven by over four billion systems shipped with Arteris System IP

  • CYCUITY ACQUISITION - Acquisition of Cycuity strengthens Arteris' ability to secure data movement in silicon, addressing cybersecurity threats

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$20.10 mln

$18.55 mln (4 Analysts)

Q4 Adjusted Net Income

Beat

-$2.30 mln

-$2.72 mln (3 Analysts)

Q4 Net Income

-$8.50 mln

Q4 Adjusted Operating Income

Beat

-$2.20 mln

-$2.66 mln (4 Analysts)

Q4 Operating Income

-$8.50 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy"

  • Wall Street's median 12-month price target for Arteris Inc is $20.50, about 35.8% above its February 11 closing price of $15.10

Press Release: ID:nGNX6pzDmW

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10